An update on recently approved long-acting injectable second-generation antipsychotics: Knowns and unknowns regarding their use

There are now 9 available FDA-approved second-generation long-acting injectable antipsychotics including aripiprazole (3), olanzapine (1), paliperidone (3), and risperidone (2). These high-cost medications are commonly used with the goal of improving adherence and patient outcomes. With almost 2 dec...

Descripción completa

Detalles Bibliográficos
Autor principal: VandenBerg, Amy M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association of Psychiatric Pharmacists 2022
Materias:
Psychopharmacology Pearls
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645288/
https://www.ncbi.nlm.nih.gov/pubmed/36405505
http://dx.doi.org/10.9740/mhc.2022.10.270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9645288/
https://www.ncbi.nlm.nih.gov/pubmed/36405505
http://dx.doi.org/10.9740/mhc.2022.10.270

Ejemplares similares